Quris AI is building a machine-learning platform that predicts which drug candidates will be safe and effective in humans. Its approach tests drugs on miniaturized "Patients-on-a-Chip" and uses the resulting automatically labeled data to train its classification models. [1]
The company is based in Boston and Tel Aviv. It was founded by CEO Isaac Bentwich and co-founder and CTO Yossi Haran, and its news page reports a $28 million seed round and a collaboration with Merck KGaA. [2]